Predict your next investment

HEALTHCARE | Drug Development
arcarios.com

See what CB Insights has to offer

Stage

Seed VC | Alive

Total Raised

$5.4M

Last Raised

$5.4M | 11 yrs ago

About Arcarios

Arcarios is a drug development company dedicated to the discovery and development of products in the field of bone and joint diseases such as osteoporosis and osteoarthritis.

Arcarios Headquarter Location

Netherlands

Latest Arcarios News

Global Bone Fracture Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Arcarios, Bone Therapeutics, TissueGene - Research and Markets

May 11, 2016

Global Bone Fracture Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Arcarios, Bone Therapeutics, TissueGene - Research and Markets May 11, 2016 02:04 PM Eastern Daylight Time DUBLIN--( BUSINESS WIRE )--Research and Markets has announced the addition of the "Bone Fracture - Pipeline Review, H1 2016" report to their offering. The report provides comprehensive information on the therapeutics under development for Bone Fracture, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Key Topics Covered: The report provides a snapshot of the global therapeutic landscape of Bone Fracture The report reviews pipeline therapeutics for Bone Fracture by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved Bone Fracture therapeutics and enlists all their major and minor projects The report assesses Bone Fracture therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type The report reviews latest news related to pipeline therapeutics for Bone Fracture Companies Mentioned:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Arcarios Patents

Arcarios has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/16/2007

3/24/2015

Transcription factors, Clusters of differentiation, Skeletal system, Human proteins, Extracellular matrix proteins

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/16/2007

00/00/0000

Grant Date

3/24/2015

00/00/0000

Title

Subscribe to see more

Related Topics

Transcription factors, Clusters of differentiation, Skeletal system, Human proteins, Extracellular matrix proteins

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.